Erasca, Inc. (ERAS)
17.26
-0.62
(-3.47%)
USD |
NASDAQ |
Sep 01, 10:01
Erasca Total Long Term Debt (Quarterly) : 39.27M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 39.27M |
| March 31, 2026 | 40.70M |
| December 31, 2025 | 42.07M |
| September 30, 2025 | 43.41M |
| June 30, 2025 | 44.71M |
| March 31, 2025 | 46.02M |
| December 31, 2024 | 47.27M |
| September 30, 2024 | 48.49M |
| June 30, 2024 | 49.68M |
| March 31, 2024 | 57.72M |
| December 31, 2023 | 51.89M |
| September 30, 2023 | 52.94M |
| June 30, 2023 | 53.97M |
| Date | Value |
|---|---|
| March 31, 2023 | 54.94M |
| December 31, 2022 | 53.79M |
| September 30, 2022 | 53.43M |
| June 30, 2022 | 27.44M |
| March 31, 2022 | 29.42M |
| December 31, 2021 | 18.51M |
| September 30, 2021 | 19.37M |
| June 30, 2021 | 1.668M |
| March 31, 2021 | 1.875M |
| December 31, 2020 | 2.109M |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Revolution Medicines, Inc. | 1.174B |
| Tango Therapeutics, Inc. | 29.05M |
| Cogent Biosciences, Inc. | 242.77M |
| Apogee Therapeutics, Inc. | 103.70M |
| Arrowhead Pharmaceuticals, Inc. | 1.371B |